Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Dec 2025 is 9.56% vs 2.21% in Dec 2024
Consolidate Net Profit
YoY Growth in quarter ended Dec 2025 is 7.09% vs -33.96% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Dec 2025 is 10.82% vs -14.13% in Dec 2024
Interest
YoY Growth in quarter ended Dec 2025 is 307.69% vs 30.00% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024
Compare Quarterly Results Of ASKA Pharmaceutical Holdings Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Dec 2025 is 9.20% vs -0.16% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 9.56% vs 2.21% in Dec 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Dec 2025 is 58.67% vs -22.77% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 7.09% vs -33.96% in Dec 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Dec 2025 is 56.00% vs -5.82% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 10.82% vs -14.13% in Dec 2024
Quarterly - Interest
QoQ Growth in quarter ended Dec 2025 is -8.62% vs 13.73% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 307.69% vs 30.00% in Dec 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025
YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024






